drugset / Trial / NCT05755750

Intratendinous Genipin Injection in Horses With Tendon Injuries

NCT05755750 ↗

Phase 3 Completed 74 enrolled University of Zurich
NaSingle-groupOpen-labelTreatment

Summary

Our study is the first to use genipin, a naturally occurring collagen cross-linking agent, as a therapeutic agent to treat superficial digital flexor tendon (SDFT) injuries in horses. The promising approach of intratendinous genipin injection and tendon mechanical enhancement could be a viable alternative to current therapies for SDFT injuries.

Timeline

Start
2016-06-28
Primary completion
2023-01-04
Completion
2023-01-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Genipin Small molecule 0.2 ml Other

Indications